✦ LIBER ✦

Pharmacokinetics and Pharmacodynamic Effects of Oral GLP-1 and PYY3-36: A Proof-of-concept Study in Healthy Subjects

✍ Scribed by Beglinger, C; Poller, B; Arbit, E; Ganzoni, C; Gass, S; Gomez-Orellana, I; Drewe, J

Book ID: 109845626
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 230 KB
Volume: 84
Category: Article
ISSN: 0009-9236
DOI: 10.1038/clpt.2008.35

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and Pharmacodynamics of

Pharmacokinetics and Pharmacodynamics of Inhaled GLP-1 (MKC253): Proof-of-Concept Studies in Healthy Normal Volunteers and in Patients With Type 2 Diabetes

✍ Marino, M T; Costello, D; Baughman, R; Boss, A; Cassidy, J; Damico, C; van Marle 📂 Article 📅 2010 🏛 Nature Publishing Group 🌐 English ⚖ 477 KB

The safety, tolerance, pharmacokinetic a

The safety, tolerance, pharmacokinetic and pharmacodynamic effects of single doses of AT-1001 in coeliac disease subjects: a proof of concept study

✍ B. M. PATERSON; K. M. LAMMERS; M. C. ARRIETA; A. FASANO; J. B. MEDDINGS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 595 KB

Effect of the oral renin inhibitor alisk

Effect of the oral renin inhibitor aliskiren on the pharmacokinetics and pharmacodynamics of a single dose of warfarin in healthy subjects

✍ Walter Dieterle; Sophie Corynen; Jessica Mann 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB

Pharmacokinetics of oral moclobemide in

Pharmacokinetics of oral moclobemide in healthy human subjects and effects on MAO-activity in platelets and excretion of urine monoamine metabolites

✍ F. -A. Wiesel; J. Raaflaub; R. Kettler 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 714 KB

Pharmacokinetics and effects on blood pr

Pharmacokinetics and effects on blood pressure of a single oral dose of milrinone in healthy subjects and in patients with renal impairment

✍ R. Larsson; H. Liedholm; K. E. Andersson; M. A. Keane; G. Henry 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 528 KB

MLN3897 plus methotrexate in patients wi

MLN3897 plus methotrexate in patients with rheumatoid arthritis: Safety, efficacy, pharmacokinetics, and pharmacodynamics of an oral CCR1 antagonist in a phase IIa, double-blind, placebo-controlled, randomized, proof-of-concept study

✍ Clarissa E. Vergunst; Danielle M. Gerlag; Lisa von Moltke; Michael Karol; Tim Wy 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 169 KB 👁 3 views

## Abstract ## Objective To assess the efficacy, safety, pharmacokinetics, and pharmacodynamics of the CC chemokine receptor CCR1 antagonist MLN3897 in patients with rheumatoid arthritis (RA) receiving methotrexate (MTX). ## Methods In this phase IIa, proof‐of‐concept study, patients meeting the